Bicara Therapeutics (BCAX) Shares Outstanding (Entity) (2023 - 2026)
Bicara Therapeutics (BCAX) recorded Shares Outstanding (Entity) of 65.93 million in Q2 2026, up 20.9% from 54.56 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Bicara Therapeutics (BCAX) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends
For FY2025, Bicara Therapeutics reported Shares Outstanding (Entity) of 56.6 million, up 236.8% from FY2024.
- Across earlier years, Shares Outstanding (Entity) came in at 16.81 million in FY2024 and 640,386 in FY2023.
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q3 2023.
- On a year-over-year basis, Shares Outstanding (Entity) has increased for four consecutive quarters, with growth averaging 169.7% over the last four quarters.
- Per Business Quant, the preceding three quarters came in at 65.55 million (Q1 2026), 56.6 million (Q4 2025) and 54.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | - |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Bicara Therapeutics | 1.22 Bn | -525.43 Mn | - | 65.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.93 Mn |
| Mar 31, 2026 | 65.55 Mn |
| Dec 31, 2025 | 56.60 Mn |
| Sep 30, 2025 | 54.61 Mn |
| Jun 30, 2025 | 54.56 Mn |
| Mar 31, 2025 | 54.53 Mn |
| Dec 31, 2024 | 16.81 Mn |
| Sep 30, 2024 | 10.90 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 640,386.00 |
| Dec 31, 2023 | 640,386.00 |
| Sep 30, 2023 | 579,975.00 |
API Access
Bicara Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=BCAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "BCAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=BCAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();